|
|||||
|
|
Estimation of cost savings between 2011 and 2014 attributed to infliximab biosimilar in the South Korean healthcare market: real‐world evidence using a nationwide database |
|
| Authors: | Inmyung Song Haesun Park Sang‐Won Lee Eui‐Kyung Lee Ju‐Young Shin |
| Institution: | School of Pharmacy, Sungkyunkwan University, Suwon, Korea |
| Abstract: | |
| Keywords: | biosimilar cost saving HIRA‐NPS infliximab |